Piramal Enterprises Limited (PEL), a publicly listed company in India, has diversified business interests in Financial Services and Pharmaceuticals. PEL’s consolidated revenues were ~US$1.7 billion in FY2020, with ~34% of revenues generated from outside India.
Anticipating the potential of financial services in India, PEL built a platform with innovative financial solutions that cater to the needs of varied industry verticals.
In Financial Services, PEL offers a wide range of financial products and solutions, with exposure across both wholesale and retail financing. The wholesale lending business provides financing to real estate developers, as well as corporate clients in non-real estate sectors. Within retail lending, the Company offers housing loans to individual customers and is building a multi-product retail lending platform. India Resurgence Fund (IndiaRF), the distressed asset investing platform in partnership with Bain Capital Credit, invests in equity and/or debt across non-real estate sectors. The Company has longstanding partnerships with leading institutional investors that include – CPPIB, APG, Bain Capital Credit, CDPQ, and Ivanhoé Cambridge. PEL also has equity investments in the Shriram Group, a leading financial conglomerate in India.
When the Indian pharmaceutical industry was focused on international generics, PEL saw an opportunity to expand its pharma business and invested in the domestic formulation business.
Piramal Pharma Limited (PPL), a subsidiary of PEL, offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 14 global facilities and a global distribution network in over 100 countries. PPL includes: Pharma Solutions, an integrated contract development and manufacturing (CDMO) business; Critical Care, a complex hospital generics business and the Consumer Healthcare business, selling over-the-counter products in India. It also has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market.
PEL’s corporate ethos, a reflection of its core values – Knowledge, Action, Care and Impact, has enabled the company to develop and consolidate a coveted international business network of strong partnerships with global market leaders, committed to creating long-term value to all stakeholders.
Operational excellence fuelled by continued innovation
Delivering sustained long-term value to all stakeholders
Fostering an environment of entrepreneurship